ASTS
AST SpaceMobile, Inc.
ASTS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CXM
Sprinklr, Inc.
CXM has the edge over ASTS overall, supported by lower modeled downside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CXM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
CXM's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CXM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $6.65 | — |
| Cheap | 18x | $1.84 | -72% |
| Fair | 47x | $4.69 | -29% |
| Current | 67x | $6.65 | — |
| Expensive | 102x | $10.23 | +54% |
Historical ranges are pointers, not guarantees.
CXM's PE is in its expensive range at 67x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CXM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CXM's earnings to grow and its profitability to improve, with its revenue holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CXM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.53 | +431% |
| Q3 2026 | $0.10 | -77% |
| Q2 2026 | $0.12 | -69% |
| Q1 2026 | $0.09 | -80% |
| Q4 2025 | $0.40 | +150% |
| Q3 2025 | $0.43 | +139% |
| Q2 2025 | $0.39 | +86% |
| Q1 2025 | $0.44 | +144% |
| Q4 2024 | $0.16 | +45% |
CXM has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CXM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $213.7M | +0.8% |
| Q2 2026 | $219.5M | +6.8% |
| Q1 2026 | $220.6M | +8.9% |
| Q4 2025 | $219.1M | +9.2% |
| Q3 2025 | $212M | +7.5% |
| Q2 2025 | $205.5M | +4.9% |
| Q1 2025 | $202.5M | +4.3% |
| Q4 2024 | $200.7M | +7.7% |
CXM's revenue has grown year over year every quarter since early 2021: $214M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.7% | -3 points |
| Q2 2026 | 4.8% | +5.7 points |
| Q1 2026 | 6.4% | +1.3 points |
| Q4 2025 | 5.3% | +1.3 points |
| Q3 2025 | 7.7% | +7.7 points |
| Q2 2025 | -0.8% | -3.8 points |
| Q1 2025 | 5.2% | -4.3 points |
| Q4 2024 | 3.9% | -3.1 points |
CXM has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CXM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $17.8M | -48% |
| Q2 2026 | $70M | -16% |
| Q1 2026 | $20.1M | +341% |
| Q4 2025 | $19.8M | +141% |
| Q3 2025 | $34.4M | +74% |
| Q2 2025 | $83.5M | +113% |
| Q1 2025 | $4.6M | -70% |
| Q4 2024 | $8.2M | -57% |
CXM has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CXM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.2% | -5.3M shares |
| 1 year | -9.6% | -25.4M shares |
| 3 years | -16% | -46M shares |
| 5 years | -5% | -12.6M shares |
| Available history | +2.8% | +6.4M shares |
CXM has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $796,000 |
| Q2 2026 | $125M |
| Q1 2026 | — |
| Q4 2025 | $11.4M |
| Q3 2025 | $140.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
CXM spent $137M buying back its own shares over the past year, down 2.6% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CXM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.6x | Net Cash |
| Q2 2026 | -2.3x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -3.6x | Net Cash |
| Q1 2025 | -3.4x | Net Cash |
| Q4 2024 | -1.9x | Net Cash |
CXM has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CXM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.8 | Neutral |
| Stochastic | 55.9 | Neutral |
CXM's weekly RSI is 56 (neutral) and its Stochastic is 56 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CXM PE vs Technology Sector
| Metric | CXM | Sector median | Relative |
|---|---|---|---|
| PE | 67x | 28x | 139% above |
| PE % | 77 | 43 | 34 pts above |
CXM is trading at 67x earnings, a 139% premium to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
CXM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.05 | 9.9% above |
| 20 week MA | $6.16 | 8% above |
| 50 week MA | $6.10 | 9% above |
| 100 week MA | $7.15 | 7% below |
| 200 week MA | $9.36 | 29% below |
CXM has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CXM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $20.5 | $16.0 | -22% |
| 2022 | $16.0 | $7.84 | -51% |
| 2023 | $7.84 | $12.0 | +54% |
| 2024 | $12.0 | $8.53 | -29% |
| 2025 | $8.53 | $7.72 | -9.5% |
| 2026 YTD | $7.72 | $6.65 | -14% |
CXM has the edge over ASTS on returns for 2026, with the stronger performance.